BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200315
DTEND;VALUE=DATE:20200320
DTSTAMP:20260430T055151
CREATED:20191209T093948Z
LAST-MODIFIED:20200304T091342Z
UID:21698-1584230400-1584662399@senzagen.com
SUMMARY:SOT Annual Meeting 2020
DESCRIPTION:Join SenzaGen’s hosted session at the SOT Annual Meeting and ToxExpo\nWill you be at SOT in Anaheim in March? Come join our hosted session to hear the latest news about GARD™ and how customers use the assays for skin and respiratory sensitization testing. We will show results from several case studies. \nHosted session\nTue\, Mar 17 at 1:30pm – 2:30pm | Room 206B\nThe Application of In Vitro GARD™ Assays for Skin and Respiratory Sensitization Assessment of “Difficult-to-Test” Substances \nSpeakers\n– Dr. Andy Forreryd\, SenzaGen AB\n– Drs. Charles Humfrey/Yafan Li/Len Sweet: Collaborators at the Lubrizol Corporation.\n– Dr. George DeGeorge\, MB Research Labs \nNo registration needed. \nWe are in booth #869 – book a meeting with us!\nYou can also meet us at our posters\nID 1180 | Board no P225 | CC Exhibit Hall | Mon\, Mar 16 at 10:45am – 12:30pm\nInter-Laboratory Ring Trial of the GARD Air Assay for Assessment of Respiratory Sensitizers—Results of Predictive Performance and Reproducibility \nID 2369 | Board no P790 | CC Exhibit Hall | Tue\, Mar 17 at 9:00am – 10:45am\nFormal Validation of the GARDpotency Assay for Subclassification of Chemical Skin Sensitizers—Ring Trial Results of Predictive Performance and Reproducibility \nID 2372 | Board number P793 | CC Exhibit Hall | Tue at Mar 17\, 9:00am – 10:45am\nApplicability of GARDskin for Accurate Assessment of Challenging Substances in the Context of Skin Sensitization Testing \nID 2808 | Board number P425 | CC Exhibit Hall | Wed\, Mar 18 at 2:15pm – 4:30pm\nEstimating the Sensitivity of GARDskin and GARDair Assays for Evaluating Skin and Respiratory Sensitization Potential of Complex Mixtures; An Initial Case Study Using Spiked E-liquids \nID 3418 | Board no P232 | CC Hall C | Thu\, Mar 19 at 8:30am – 11:30am\nExtended Applicability Domain of the GARD Platform by Solvent-Extraction Protocols Allows for Accurate Assessment of Sensitizing Mixtures and UVCBs
URL:https://senzagen.com/event/sot-annual-meeting-2020/
LOCATION:Anaheim\, CA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/12/SOT2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200225
DTEND;VALUE=DATE:20200226
DTSTAMP:20260430T055151
CREATED:20200206T094818Z
LAST-MODIFIED:20200211T161137Z
UID:21979-1582588800-1582675199@senzagen.com
SUMMARY:Free webinar: In vitro sensitization testing based on genomics and machine learning
DESCRIPTION:All you need to know about the GARD™ assays for skin and respiratory sensitization testing \nDid you miss our popular webinar ‘GARD technology: Genomics and Machine Learning’ last year? Here is a new opportunity to participate in a live webinar presented by GARD experts at SenzaGen followed by a Q&A session. \nJoin us and you’ll learn the principles of the technology platform and get an updated overview of its broad applicability. This webinar will give you in-depth knowledge about GARD. \nKey takeaways \n\nThe story behind the development of the technology platform\nHow the platform works and why it is highly accurate – the prediction model\, genomics and machine learning technology\nApplicability of the GARD assays – what chemicals have been tested? How about complex mixtures\, natural extracts and low solubility substances?\n\nAvailable on two occasions \nEU Time Zone | Feb 25\, 11:00 CET | Register here\nUS Time Zone | Feb 25\, 11:00 EST| Register here \n 
URL:https://senzagen.com/event/free-webinar-in-vitro-sensitization-testing-based-on-genomics-and-machine-learning/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/02/Banner_Linkedin_webinar_bullets.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191211
DTEND;VALUE=DATE:20191213
DTSTAMP:20260430T055151
CREATED:20191121T074358Z
LAST-MODIFIED:20191126T083205Z
UID:21610-1576022400-1576195199@senzagen.com
SUMMARY:PCRM's NURA Training
DESCRIPTION:Integrating Modern Science Approaches \nSpeaker: Joshua Schmidt\, PhD. GARD as part of Integrated Strategy. \n 
URL:https://senzagen.com/event/pcrms-nura-training/
LOCATION:Houston\, TX
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/11/NURA-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191202
DTEND;VALUE=DATE:20191205
DTSTAMP:20260430T055151
CREATED:20191122T163706Z
LAST-MODIFIED:20191129T072428Z
UID:21621-1575244800-1575503999@senzagen.com
SUMMARY:The Society of Toxicology of Canada 51th Annual Symposium
DESCRIPTION:
URL:https://senzagen.com/event/the-society-of-toxicology-of-canada-51th-annual-symposium/
LOCATION:Ottawa\, Canada
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/11/stc1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191117
DTEND;VALUE=DATE:20191121
DTSTAMP:20260430T055151
CREATED:20190917T150236Z
LAST-MODIFIED:20190917T150236Z
UID:20223-1573948800-1574294399@senzagen.com
SUMMARY:ACT 40th Annual Meeting
DESCRIPTION:The 40th Annual Meeting will include a wide-ranging scientific program\, a welcome reception\, the popular traditional poster session reception\, an awards ceremony and luncheon\, distinguished plenary speakers\, and numerous professional networking events.
URL:https://senzagen.com/event/act-40th-annual-meeting/
LOCATION:Phoenix\, Arizona\, USA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/ACT2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191106
DTEND;VALUE=DATE:20191108
DTSTAMP:20260430T055151
CREATED:20190917T142949Z
LAST-MODIFIED:20190918T063533Z
UID:20214-1572998400-1573171199@senzagen.com
SUMMARY:Training: In Vitro Assays Development & Good In Vitro Method Practices
DESCRIPTION:This training will illustrate various aspects of the OECD Good In Vitro Methods Practices (GIVIMP) guidance document (STA 286) using assays/techniques/test systems that have been developed recently by the different trainers. It aims to provide the participants with hands-on\, practical skills in how to apply GIVIMP in their daily work in the laboratory\, and at the same time learn about modern techniques used for in vitro testing. \nHands-on Training with SenzaGen \nNov 6\, 2019 \n14:00 – 14:30 Hands-on Training\ngroup B : Solubility / Rose Marie Jenvert – SenzaGen \n14:30 – 15:00 Hands-on Training\ngroup A : Solubility / Rose Marie Jenvert – SenzaGen
URL:https://senzagen.com/event/in-vitro-assays-development-good-in-vitro-method-practices/
LOCATION:Gothenburg\, Sweden
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/cropped-altertox_academy_logo-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191104
DTEND;VALUE=DATE:20191106
DTSTAMP:20260430T055151
CREATED:20190918T064832Z
LAST-MODIFIED:20190918T064832Z
UID:20231-1572825600-1572998399@senzagen.com
SUMMARY:Le congrès annuel de la SFT
DESCRIPTION:Nouveaux Modèles\, Nouvelles Approches\, Nouveaux Défis en Évaluation du Risque \nProgramme Nov 4 2019 \n14 h 45 – 15 h 15 Nouveaux modèles en sensibilisation in vitro \n2. In vitro assessment of respiratory sensitisation: the GARDair test\nAndy FORRERYD\, SenzaGen\, Lund (Suède) \nFull programme
URL:https://senzagen.com/event/le-congres-annuel-de-la-sft/
LOCATION:Paris\, France
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/logo_sft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191024
DTSTAMP:20260430T055151
CREATED:20190918T155444Z
LAST-MODIFIED:20191002T063647Z
UID:20273-1571788800-1571875199@senzagen.com
SUMMARY:Free webinar: In vitro skin sensitization testing of Medical Devices
DESCRIPTION:GARD™skin Medical Device – All you need to know about the GARD™ technology for in vitro sensitization testing of Medical Devices\nJoin Dr Rose-Marie Jenvert from SenzaGen for a webinar on how the in vitro GARD™skin Medical Device can be used for skin sensitization testing of polar and non-polar extractions of Medical Devices. \nKey takeaways\n\nHow GARD™skin Medical Device can be used for skin sensitization testing of Medical Devices.\nUse of polar and non-polar extraction vehicles.\nCase studies showing how GARD™skin Medical Device be used during product development\, for final products and during product life cycle.\n\nAvailable on two occasions\nEU Time Zone | 23 Oct\, 15:00 CET | Registration\nUS Time Zone | 23 Oct\, 13:00 EDT| Registration
URL:https://senzagen.com/event/free-webinar-in-vitro-skin-sensitization-testing-of-medical-devices/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/Webinar_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191001
DTEND;VALUE=DATE:20191003
DTSTAMP:20260430T055151
CREATED:20190904T151004Z
LAST-MODIFIED:20190925T120839Z
UID:20057-1569888000-1570060799@senzagen.com
SUMMARY:The 3rd Symbioteq Biocompatibility of Medical Devices Conference 2019
DESCRIPTION:The conference gives you the opportunity for learning the latest news within biocompatibility together with excellent networking\, being a specialist or beginner within biocompatibility/toxicology? Product safety\, material specialist\, within material characterization\, for those of you in development\, production\, process development or Quality Assurance/Regulatory Affairs\, we are sure you will have a rewarding few days in Gothenburg. \nProgram Oct 1\n14.00\nThird session: In Vitro Methods\, Progress and Hurdles\nCo-chair: Rose-Marie Jenvert PhD\, Product Manager\, SenzaGen\, Sweden. Member of SIS/TC 340 and Swedish expert in ISO TC 194 \nLink to full program
URL:https://senzagen.com/event/the-3rd-symbioteq-biocompatibility-of-medical-devices-conference-2019/
LOCATION:Gothenburg\, Sweden
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/Biocompatibility.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190926
DTSTAMP:20260430T055151
CREATED:20190821T125536Z
LAST-MODIFIED:20190918T160256Z
UID:19919-1569369600-1569455999@senzagen.com
SUMMARY:Free webinar: How are the in vitro GARD™assays used in real life?
DESCRIPTION:Cases and applications for testing of skin and respiratory sensitizers\nJoin Dr Andy Forreryd from SenzaGen for a webinar on how the in vitro GARD assays are used across industries to test for skin and respiratory sensitizers. Andy will focus on the benefits of the GARD assays and walk you through several relevant examples of their applications. \nKey takeways\n\nHow the GARD assays are used for assessment of UVCBs\, hair dye products\, oil-based mixtures\, base formulations and medical devices.\nHow to differentiate between skin sensitizers and respiratory sensitizers by combining GARDskin and GARDair.\nHow to obtain potency classifications (GHS CLP) using GARDpotency.\n\n  \nAvailable on two occasions\nEU Time Zone | 25 Sept\, 15:00 CET | > Register here  \nUS Time Zone | 25 Sept\, 13:00 EDT| > Register here \n  \nAbout GARD\nHigh information\, high accuracy\nThe GARD tests are developed by combining genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitizers. This holistic\, high-information approach provides robust predictions with accuracies exceeding 90%. \nWith its high accuracy\, demonstrated human relevance and broad applicability\, the GARD assays can support your unique chemical testing requirements. \nAvailable GARD assays \n\nSkin sensitization: GARDskin\, GARDskin Medical Device NEW!\nPotency classification: GARDpotency\nRespiratory sensitization: GARDair\n\n  \n  \n  \n 
URL:https://senzagen.com/event/webinar-how-are-the-in-vitro-gardassays-used-in-real-life/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190927
DTSTAMP:20260430T055151
CREATED:20190904T152040Z
LAST-MODIFIED:20190919T112809Z
UID:20064-1569283200-1569542399@senzagen.com
SUMMARY:8th Annual Meeting of the ASCCT
DESCRIPTION:Computational Toxicology: Peeking into the Clouds while Keeping our Feet on Solid Ground \nThursday\, September 26\n9:50: Session III\nThe GARD platform: Cutting-edge technology using genomics and machine learning to test for various toxicological endpoints (Schmidt\, Senzagen)
URL:https://senzagen.com/event/8th-annual-meeting-of-the-ascct/
LOCATION:Gaithersburg\, Md\, USA
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/ascct-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190919
DTSTAMP:20260430T055151
CREATED:20190903T122804Z
LAST-MODIFIED:20190917T105358Z
UID:20037-1568764800-1568851199@senzagen.com
SUMMARY:North American Biocompatibility Summit (NABS)
DESCRIPTION:(NABS)\, a limited-seating event that will provide industry insights and expertise sharing on the biocompatibility of medical devices\, including the latest regulatory updates\, biological evaluation strategies and best practices that lead to successful biocompatibility programs. \nSessions will be led by the medical device industry’s foremost biological safety experts.
URL:https://senzagen.com/event/north-american-biocompatibility-summit-nabs/
LOCATION:Minneapolis\, USA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/nabs-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190908
DTEND;VALUE=DATE:20190912
DTSTAMP:20260430T055151
CREATED:20190520T115547Z
LAST-MODIFIED:20190904T070917Z
UID:19586-1567900800-1568246399@senzagen.com
SUMMARY:EUROTOX 2019
DESCRIPTION:Will you be at Eurotox in Helsinki in September? We are looking forward to meeting you and to share the latest news about the GARD assay platform development. \nAt the conference\, we will launch GARD®skin Medical Device for biocompatibility assessment of medical devices. Our expert Dr Rose-Marie Jenvert will attend and present a poster during the session on Monday 9 Sept. Read more or book a meeting with her to learn more about this exciting new assay! \nWe will also present our latest data on solvent selection at the same poster session. Dr Olivia Larne will be available to answer your questions.\n\nMeet our team at our booth #36! \nView our posters\n \nID 482 | Viewing 1 | Board no P06-054 | Monday\, Sept 9 from 09:00\nIn vitro skin sensitization testing of Medical Devices using GARD® \nID 835 | Viewing 1 | Board number P-06-100 | Monday\, Sept 9 from 09:00\nExtended solvent selection for in vitro sensitization testing using GARD®
URL:https://senzagen.com/event/eurotox-2019/
LOCATION:Helsinki\, Finland\, Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/05/eurotox19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190905
DTEND;VALUE=DATE:20190907
DTSTAMP:20260430T055151
CREATED:20190904T074157Z
LAST-MODIFIED:20190904T074240Z
UID:20048-1567641600-1567814399@senzagen.com
SUMMARY:The 29th Annual BioInterface Workshop & Symposium
DESCRIPTION:
URL:https://senzagen.com/event/the-29th-annual-biointerface-workshop-symposium-2/
LOCATION:Park City\, USA\, UT\, United States
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/biointerface-2019-b-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190715
DTEND;VALUE=DATE:20190719
DTSTAMP:20260430T055151
CREATED:20190520T094342Z
LAST-MODIFIED:20190520T095110Z
UID:19562-1563148800-1563494399@senzagen.com
SUMMARY:IUTOX – The 15th International Congress Of Toxicology
DESCRIPTION:IUTOX and the Society of Toxicology\, USA (SOT) are pleased to announce the next triennial International Congress of Toxicology (ICT) to be held July 15–18\, 2019\, at the Hawaii Convention Center in Honolulu\, Hawaii\, USA—a forum for scientists in academia\, government\, and industry from around the world to learn about the latest developments in toxicological science and regulation.
URL:https://senzagen.com/event/iutox/
LOCATION:Honolulu\, Hawaii\, Honolulu\, HI\, United States
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/05/IUTOX-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190612T110000
DTEND;TZID=America/New_York:20190612T120000
DTSTAMP:20260430T055151
CREATED:20190524T090118Z
LAST-MODIFIED:20190524T090507Z
UID:19611-1560337200-1560340800@senzagen.com
SUMMARY:ASCCT & ESTIV GARDair Webinar
DESCRIPTION:GARD™air – An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning \nPresenter: Joshua Schmidt\, SenzaGen Inc.\, USA\nCo-author: Andy Forreryd\, SenzaGen AB\, Lund\, Sweden \nRegistration link: https://attendee.gotowebinar.com/register/2480462347058889485
URL:https://senzagen.com/event/ascct-estiv-gardair-webinar/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/05/ASCCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190612
DTEND;VALUE=DATE:20190614
DTSTAMP:20260430T055151
CREATED:20190308T123912Z
LAST-MODIFIED:20190520T095659Z
UID:18852-1560297600-1560470399@senzagen.com
SUMMARY:NVT Annual Meeting\, Dutch Society of Toxicology
DESCRIPTION:Presentation by Dr. Andy Forreryd \nSession: Developing in vitro based alternatives to animal testing\nDate: 13 June\nTime: 14:00-15:30\nChair: Prof. Juliette Legler\nSpeakers: Dr. Ivan Kopljar\, Dr. Peter Racz\, Dr. Andy Forreryd \nThe 40th NVT annual meeting will be all about innovation through integration. We will be looking to identify the gaps between academia\, industry and regulatory\, between different academic fields\, and within academic fields. Once we know the gaps\, we can build the bridges that are needed for better integration and better science. The meeting’s programme will be developed in collaboration with all of the NVT sections. \n  \n 
URL:https://senzagen.com/event/nvt-annual-meeting-dutch-society-of-toxicology/
LOCATION:Ede\, Netherlands\, Ede\, Netherlands
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/03/Small-NVT-Toxicology-text-leaf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190418T140000
DTEND;TZID=America/New_York:20190418T150000
DTSTAMP:20260430T055151
CREATED:20190308T123043Z
LAST-MODIFIED:20190308T124943Z
UID:18848-1555596000-1555599600@senzagen.com
SUMMARY:Free Webinar: Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing (US)
DESCRIPTION:AMERICAN TIMEZONE  2 am EDT \nAre you curious about potential applications of genomics or machine learning?  Have you ever wondered how the GARD test platform works?  This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers.  This will include an in-depth explanation of this unique technology\, how it works\, and why it is highly accurate and has such robust prediction.   \nThis presentation will include discussions on: \n\nThe background of the genomic-based GARD™ test with an accuracy over 90% and how it compares and combines with other in vivo and in vitro sensitization assays\nComprehensive description of the GARD algorithm and how the technology actually works\n\nGenomics as a tool for analysis of immunotoxicological responses\nMethod development steps beginning with screening the entire human genome on array platforms for relevant biomarkers to a streamlining the analytical model. This will include the benefits of a data driven approach in test development providing a holistic view of the immunological response.\nA short introduction and explanation of the prediction model and how machine learning algorithms are applied for classifying results. What does the model do? Does it change? How can pattern recognition models be applied to biological gene expression data?\n\n\nOne platform enabling several tests – How is this possible?\nSimple to use\, easy and transparent classifications\, no expert judgements required\nApplicability of the GARD™platform – What chemicals can I test in GARD? How can this in vitro test analyse “difficult to test substances”\, mixtures\, pre-pro haptens\, UVCBs\, etc? Including GARD test cases and what types of chemicals have been tested already.\nWhere can I get my testing done?\n\n  \nWhat should I know before the webinar?\nNo previous knowledge about GARD is required. No technical background on genomics\, machine learning algorithms\, or programming required. No bioinformatics or immunological expertise required. \n  \nWho should attend?   \n\nAnyone interested in the GARD technology.\nRegulators\, policymakers\, or CROs who want to understand more about the technology.\nSafety Assessors\, Responsible Persons\, Product Development managers and testers\, Product Safety managers and assistants\, Lab personnel\, and anyone concerned with assessing product safety or toxicology.\nAnyone interested in learning about genomics and next generation animal-free test development for hazard assessments\n\nFor registration KLICK HERE
URL:https://senzagen.com/event/genomics-and-machine-learning-all-you-need-to-know-about-the-gard-technology-for-in-vitro-sensitization-testing-2/
LOCATION:GoToWebinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20190417T110000
DTEND;TZID=Europe/Stockholm:20190417T120000
DTSTAMP:20260430T055151
CREATED:20190308T121723Z
LAST-MODIFIED:20190308T125007Z
UID:18838-1555498800-1555502400@senzagen.com
SUMMARY:Free webinar: Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing (EUR)
DESCRIPTION:EUROPEAN TIMEZONE \nAre you curious about potential applications of genomics or machine learning?  Have you ever wondered how the GARD test platform works?  This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers.  This will include an in-depth explanation of this unique technology\, how it works\, and why it is highly accurate and has such robust prediction.   \nThis presentation will include discussions on \n\nThe background of the genomic-based GARD™ test with an accuracy over 90% and how it compares and combines with other in vivo and in vitro sensitization assays\nComprehensive description of the GARD algorithm and how the technology actually works\n\nGenomics as a tool for analysis of immunotoxicological responses\nMethod development steps beginning with screening the entire human genome on array platforms for relevant biomarkers to a streamlining the analytical model. This will include the benefits of a data driven approach in test development providing a holistic view of the immunological response.\nA short introduction and explanation of the prediction model and how machine learning algorithms are applied for classifying results. What does the model do? Does it change? How can pattern recognition models be applied to biological gene expression data?\n\n\nOne platform enabling several tests – How is this possible?\nSimple to use\, easy and transparent classifications\, no expert judgements required\nApplicability of the GARD™platform – What chemicals can I test in GARD? How can this in vitro test analyse “difficult to test substances”\, mixtures\, pre-pro haptens\, UVCBs\, etc? Including GARD test cases and what types of chemicals have been tested already.\nWhere can I get my testing done?\n\n  \nWhat should I know before the webinar?\nNo previous knowledge about GARD is required. No technical background on genomics\, machine learning algorithms\, or programming required. No bioinformatics or immunological expertise required. \n  \nWho should attend?   \n\nAnyone interested in the GARD technology.\nRegulators\, policymakers\, or CROs who want to understand more about the technology.\nSafety Assessors\, Responsible Persons\, Product Development managers and testers\, Product Safety managers and assistants\, Lab personnel\, and anyone concerned with assessing product safety or toxicology.\nAnyone interested in learning about genomics and next generation animal-free test development for hazard assessments.\n\nFor registration KLICK HERE  \n 
URL:https://senzagen.com/event/genomics-and-machine-learning-all-you-need-to-know-about-the-gard-technology-for-in-vitro-sensitization-testing/
LOCATION:GoToWebinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190402
DTEND;VALUE=DATE:20190405
DTSTAMP:20260430T055151
CREATED:20190308T124609Z
LAST-MODIFIED:20190325T133250Z
UID:18859-1554163200-1554422399@senzagen.com
SUMMARY:in-cosmetics global
DESCRIPTION:Heading into its 30th edition in 2019\, in-cosmetics Global is the leading event for personal care ingredients. The exhibition brings together personal care ingredients suppliers (exhibitors) with finished product manufacturers (visitors)\, each looking to network\, learn about future trends\, and discover new products. \nSenzaGen will participate and attend workshops
URL:https://senzagen.com/event/in-cosmetics-global/
LOCATION:Paris\, France
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/03/in-cosmetics-Global.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20190310T080000
DTEND;TZID=Europe/Stockholm:20190314T170000
DTSTAMP:20260430T055151
CREATED:20190129T084031Z
LAST-MODIFIED:20190311T174040Z
UID:18585-1552204800-1552582800@senzagen.com
SUMMARY:SOT 58th Annual Meeting and ToxExpo
DESCRIPTION:SenzaGen will exhibit at Booth #3652  \nShare your knowledge at the largest toxicology meeting in the world and get the latest updates on the advances in toxicology by attending the SOT 58 Annual Meeting and ToxExpo\, in Baltimore\, Maryland\, USA. \nSenzaGen poster sessions at CC Exhibit Hall\, further details below: \nTitle: A Novel 68-Gene Biomarker Signature to Identify Respiratory Irritation/Toxicity Induced by Inhaled Compounds – Using Machine-Learning Assisted Classifications Based on Transcriptomic Data from Calu-3 Cells. \nAbstract Number: 1437\nPoster Board number: P503\nPresentation Date: March 11\, at 2019 9:15:00 AM to 4:30:00 PM \nTitle: Extended Applicability Domain for GARD with Vehicles for Medical Device\nAbstract Number: 2948\nPoster Board number: P382\nPresentation Date: March 13\, 2019 at 9:15:00 AM to 4:30:00 PM \n \n 
URL:https://senzagen.com/event/sot-58th-annual-meeting-and-toxexpo/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/01/SOT-AM19-Email-Banner1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190207T120000
DTEND;TZID=Europe/Helsinki:20190208T120000
DTSTAMP:20260430T055151
CREATED:20190115T132257Z
LAST-MODIFIED:20190115T133053Z
UID:18573-1549540800-1549627200@senzagen.com
SUMMARY:Joint EPAA/ Cefic-LRI / IFRA Europe Training and Knowledge-sharing workshop 2019
DESCRIPTION:SenzaGen is attending the Training and Knowledge-sharing Workshop – “Applying non-animal strategies for assessing skin sensitization” in Helsinki\, Finland. \nThe main objective of the workshop is to discuss how the information produced from non-animal assays for skin sensitisation can be used in regulatory decision-making for hazard identification (classification & labelling) but also for risk assessment decisions\, i.e. by taking potency into account. \n  \n  \n 
URL:https://senzagen.com/event/joint-epaa-cefic-lri-ifra-europe-training-and-knowledge-sharing-workshop-2019/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/01/Helsinki_2019_-joint-event_feb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181213
DTSTAMP:20260430T055151
CREATED:20181029T111645Z
LAST-MODIFIED:20181029T172652Z
UID:18070-1544400000-1544659199@senzagen.com
SUMMARY:The Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018
DESCRIPTION:SenzaGen is participating at \nThe Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018\nWHAT’S IN A NAM ?  (NOVEL APPROACH METHODOLOGIES). \nBENEFITS\, LIMITATIONS\, TRANSLATION\, COMMUNICATION. \n| DECEMBER 10 TO 12\, 2018 |\n| VENUE:  COURTYARD BY MARRIOTT – TORONTO | \nThe Society of Toxicology of Canada Inc. is a non-profit association whose objectives are to promote the acquisition\, facilitate the dissemination\, and encourage the utilization of knowledge in the science of toxicology. \nThe STC supports continuing education and excellence in research through its Annual Symposium\, which provides a venue for members and international experts to present the latest advances in experimental and regulatory toxicology. \nThe Society recognizes the universality of science and adheres to principles which affirm membership and free circulation of bona fide scientists in a non-discriminatory fashion.
URL:https://senzagen.com/event/the-society-of-toxicology-of-canada-50th-annual-symposium-winter-2018/
LOCATION:COURTYARD BY MARRIOTT – TORONTO DOWNTOWN
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/toronto-city.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181205T130000
DTEND;TZID=America/New_York:20181205T140000
DTSTAMP:20260430T055151
CREATED:20181105T160248Z
LAST-MODIFIED:20181106T104647Z
UID:18240-1544014800-1544018400@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasion. This one targeted forthe US audience at 13:00 EST  (19:00 CET) \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs.\n\n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™ \nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy \n\nDon’t miss the opportunity to learn more from our researchers. Welocome to join! \nREGISTER HERE \n  \n 
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen-2/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20181204T150000
DTEND;TZID=Europe/Stockholm:20181204T160000
DTSTAMP:20260430T055151
CREATED:20181105T160230Z
LAST-MODIFIED:20181106T104722Z
UID:18231-1543935600-1543939200@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasions\, this one targeted for the EUROPEAN time zone \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\n\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs. \n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™\nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy. \nDon’t miss the opportunity to learn more from our researchers. Welcome to join! \nREGISTER HERE
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20181129T080000
DTEND;TZID=Europe/Stockholm:20181129T170000
DTSTAMP:20260430T055151
CREATED:20181029T130514Z
LAST-MODIFIED:20181029T151616Z
UID:18108-1543478400-1543510800@senzagen.com
SUMMARY:EUROFINS Human Safety Seminar - in vitro Toxicology at a Glance. Today's Challenges\, Solutions & Future Developments
DESCRIPTION:Dr Andy Forreryd is one of three speakers at the Human Safety Seminar organised by Eurofins BioPharma Product Testing Munich where he is to present the GARD platform for skin and respiratory sensitization  \nTopics for the seminar:  \n\nIn vitro Methods to test for Endocrine Disrupting Properties  \nIn vitro Skin sensitization – Challenges to Overcome \nEye Irritation ex vivo and in vitro methods – Current status \nGARD platform\, genomic test for skin and respiratory sensitization with potency classification  \nNew Developments in Genotoxicity Testing for Chemicals\, Cosmetics and Pharmaceuticals – in vitro and in vivo Comet Assay \n\nFor more information and registration  \nhttps://www.eurofins.com/human-safety-seminar
URL:https://senzagen.com/event/eurofins-human-safety-seminar-in-vitro-toxicology-at-a-glance-todays-challenges-solutions-future-developments/
LOCATION:Eurofins Munich\, Robert-Koch-Straße 3a\, Planegg
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/save-the-date_final_web.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181129
DTSTAMP:20260430T055151
CREATED:20181029T144439Z
LAST-MODIFIED:20181031T092502Z
UID:18057-1543276800-1543449599@senzagen.com
SUMMARY:SFT - Société Francaise de Toxicologie
DESCRIPTION:En 2018\, le congrès annuel de la SFT a lieu à Lille\, les 27 et 28 novembre\, espace Jeanne de Flandre (Lille Grand Palais). \nPoster\nGARD® – in vitro safety assessment of skin and respiratory sensitizers using a genomics-based platform \nMeet Anna Cherouvrier Hansson at the conference. To book a meeting\, please email: anna.c.hansson (at) senzagen.com
URL:https://senzagen.com/event/sft-societe-francaise-de-toxicologie/
LOCATION:Lille Grand Palais\, France
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/logo_sft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181130
DTSTAMP:20260430T055151
CREATED:20180911T085055Z
LAST-MODIFIED:20181102T123937Z
UID:17541-1543276800-1543535999@senzagen.com
SUMMARY:Biocompatibility for Medical Devices\, Barcelona\, Spain
DESCRIPTION:SenzaGen is participating at the Biocompatibility for Medical Devices\, Barcelona. \nUpdates and changes to the ISO 10993 standards\, regulatory updates and case studies of how to use ISO 10993 for evaluation of Medical Devices\nISO 10993: ARE YOU BIOCOMPATIBLE?\nRisk Mitigation. Chemical Characterisation. Practical Implementation. \n  \nMeet our Medical Device experts Rose-Marie Jenvert and Joshua Schmidt  at the conference! \nTo book a meeting\, please email them\nrose-marie.jenvert (a) senzagen.com\njoshua.schmidt (a) senzagen.com
URL:https://senzagen.com/event/biocompatibility-for-medical-devices-barcelona-spain/
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/05/Biocompatibility-for-Medical-Devices-logo-COLOR-5ba41af89b878f0aae531e1751febc8a.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181105
DTEND;VALUE=DATE:20181108
DTSTAMP:20260430T055151
CREATED:20180911T084622Z
LAST-MODIFIED:20180911T084634Z
UID:17535-1541376000-1541635199@senzagen.com
SUMMARY:Bio Europe\, Copenhagen\, Denmark
DESCRIPTION:24th annual conference
URL:https://senzagen.com/event/bio-europe-copenhagen-denmark/
LOCATION:Copenhagen\, Denmark
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/05/BEU18-Logos-NEW-05-999add75136ab900b4a4c046561f6920.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181104
DTEND;VALUE=DATE:20181108
DTSTAMP:20260430T055151
CREATED:20181029T172737Z
LAST-MODIFIED:20181029T172737Z
UID:18092-1541289600-1541635199@senzagen.com
SUMMARY:ACT 2018 – American College of Toxicology Annual Meeting
DESCRIPTION:SenzaGen is participating at The American College of Toxicology 2018 Annual Meeting that will be held Nov. 4-7 in West Palm Beach. \nThis year’s meeting will feature lectures\, poster sessions\, and other events for today’s toxicologists to network with each other and hone their skills. \nFor more information on ACT 2018\, please visit www.actox.org.
URL:https://senzagen.com/event/act-2018-american-college-of-toxicology-annual-meeting/
LOCATION:Palm Beach County Convention Center
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/10/ACT-hp-slider4inner2f.png
END:VEVENT
END:VCALENDAR